University of Nairobi
- Country
- 🇰🇪Kenya
- Ownership
- Private
- Established
- 1956-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uonbi.ac.ke
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Investigating the Optimal Management of Dolutegravir Resistance
- Conditions
- HIV-1-infection
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- University of Nairobi
- Target Recruit Count
- 6600
- Registration Number
- NCT06762054
- Locations
- 🇰🇪
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
🇰🇪Bomu Hospital, Mombasa, Kenya
🇰🇪Kenyatta National Hospital, Nairobi, Kenya
Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
- Conditions
- HIV-1-infection
- Interventions
- Drug: Darunavir+Ritonavir
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- University of Nairobi
- Target Recruit Count
- 392
- Registration Number
- NCT06747507
- Locations
- 🇰🇪
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
🇰🇪Bomu Hospital, Mombasa, Kenya
🇰🇪Kenyatta National Hospital, Nairobi, Kenya
B/F/TAF to DTG/3TC Switch Study
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- University of Nairobi
- Target Recruit Count
- 240
- Registration Number
- NCT06444620
- Locations
- 🇰🇪
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
🇰🇪Kenyatta National Hospital, Nairobi, Kenya
Psychoeducation, Relaxation, PrOblem Solving, Activation, Cognitive Coping Therapy for Adolescents and Youth in HIV Care
- Conditions
- Depression, AnxietyHIV-1-infectionTrauma
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- University of Nairobi
- Target Recruit Count
- 600
- Registration Number
- NCT06247527
- Locations
- 🇰🇪
University of Nairobi, Nairobi, Kenya
BFTAF Elderly Switch Study
- Conditions
- HIV-1-infection
- Interventions
- Drug: Switch to B/F/TAFDrug: Continue current regimen
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Nairobi
- Target Recruit Count
- 520
- Registration Number
- NCT05243602
- Locations
- 🇰🇪
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
🇰🇪Kenyatta National Hospital, Nairobi, Kenya
- Prev
- 1
- 2
- 3
- Next
News
East Africa Launches Regional Drug Research Hub in Kenya and Expands Health Security Network
Kenya has been selected to host the East Africa Regional Centre of Excellence in Bioequivalence Studies and Pharmaceutical Research at the University of Nairobi, marking a significant step toward pharmaceutical self-reliance in the region.